Press Coverage
Sofinnova Telethon
Sofinnova Partners charging ahead in Italy
Related Deal lead
Graziano SeghezziRelated Strategy
TelethonCorriere Della Sera, the leading Italian daily, published an article Nov. 22 detailing how Sofinnova Partners is "charging ahead" in Italy, investing €46 million in the country over 2 years and picking up an increasing number of local investors for Sofinnova Partners' Italian projects, the Sofinnova Telethon Strategy and the BiovelocIta accelerator.
"All the work we have done in Italy since 2015 has borne fruit," Graziano Seghezzi, managing partner at Sofinnova Partners, is quoted as saying. "We closed more than half of the 15 investments announced. We tripled the number of Italian investors in our fund, now they are 17 between institutional investors and family offices.”
Seghezzi pointed out that Sofinnova’s Milan offices house the “largest team in Italy dedicated to biotechnology” and that the company assessed 500 investments in Italy over the past three years.
Read the original article, written by Alessandra Puato and published in the weekly insert L'Economia (In Italian).
Related News
Lupin and Tenpoint Therapeutics Announce Strategic Partnership to Commercialize YUVEZZI in the European Union, the United Kingdom, Switzerland, Norway, and Iceland
HotSpot Therapeutics appoints Niti Goel, M.D., as Chief Medical Officer
Mission Therapeutics strikes deal worth up to $292 million for Dimerix Ltd to develop Acute Kidney Injury asset MTX652, sharpens focus on its CNS pipeline
Tenpoint Therapeutics Announces United Kingdom YUVEZZI™ Submission of Marketing Authorization Application to the Medicines and Healthcare Products Regulatory Agency for the Treatment of Blurry Close-Up Vision (Presbyopia) in Adults
Genespire and SR-TIGET Show Durable Preclinical Efficacy of Liver-Directed Gene Therapy for Methylmalonic Acidemia